tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AU:NEU Stock Latest News

Neuren Pharmaceuticals Focuses on Neurodevelopmental Advancements at J.P. Morgan Conference
Company AnnouncementsNeuren Pharmaceuticals Focuses on Neurodevelopmental Advancements at J.P. Morgan Conference
3d ago
Neuren’s Trofinetide Moves Closer to European Approval for Rett Syndrome
PremiumCompany Announcements
Neuren’s Trofinetide Moves Closer to European Approval for Rett Syndrome
5d ago
Neuren Pharmaceuticals Announces Share Buy-Back Program
PremiumCompany Announcements
Neuren Pharmaceuticals Announces Share Buy-Back Program
1M ago
Neuren Pharmaceuticals Boosts Buy-Back Program
PremiumCompany Announcements
Neuren Pharmaceuticals Boosts Buy-Back Program
1M ago
Neuren Pharmaceuticals Gains from Acadia’s $150M Voucher Sale
PremiumCompany Announcements
Neuren Pharmaceuticals Gains from Acadia’s $150M Voucher Sale
1M ago
Neuren Pharmaceuticals Updates on Share Buy-Back Program
PremiumCompany AnnouncementsNeuren Pharmaceuticals Updates on Share Buy-Back Program
1M ago
Neuren Pharmaceuticals’ Strategic Share Buy-Back Update
Premium
Company Announcements
Neuren Pharmaceuticals’ Strategic Share Buy-Back Update
1M ago
Neuren Pharmaceuticals Boosts Shareholder Value with Buy-Back
Premium
Company Announcements
Neuren Pharmaceuticals Boosts Shareholder Value with Buy-Back
1M ago
Neuren Pharmaceuticals Enhances Shareholder Value with Buy-Back
PremiumCompany Announcements
Neuren Pharmaceuticals Enhances Shareholder Value with Buy-Back
1M ago
Neuren Pharmaceuticals Initiates Strategic Daily Share Buy-Back
PremiumCompany Announcements
Neuren Pharmaceuticals Initiates Strategic Daily Share Buy-Back
2M ago
Neuren Pharmaceuticals’ Commitment to Neurodevelopmental Care
PremiumCompany Announcements
Neuren Pharmaceuticals’ Commitment to Neurodevelopmental Care
2M ago
Neuren Pharmaceuticals Unveils A$50 Million Share Buy-Back
PremiumCompany Announcements
Neuren Pharmaceuticals Unveils A$50 Million Share Buy-Back
2M ago
Neuren Pharmaceuticals Reports Strong Q3 Financial Growth
PremiumCompany AnnouncementsNeuren Pharmaceuticals Reports Strong Q3 Financial Growth
2M ago
Neuren Pharmaceuticals Gains from Voucher Sale
Premium
Company Announcements
Neuren Pharmaceuticals Gains from Voucher Sale
2M ago
Neuren Pharmaceuticals Updates Policy Amid Financial Growth
Premium
Company Announcements
Neuren Pharmaceuticals Updates Policy Amid Financial Growth
3M ago
Neuren’s DAYBUE Gains Canadian Approval, Expanding Market
PremiumCompany Announcements
Neuren’s DAYBUE Gains Canadian Approval, Expanding Market
3M ago
Neuren Pharmaceuticals Advances PMS Treatment Trials
PremiumCompany Announcements
Neuren Pharmaceuticals Advances PMS Treatment Trials
3M ago
Neuren Pharmaceuticals Sees Surge in H1 Revenue
PremiumCompany Announcements
Neuren Pharmaceuticals Sees Surge in H1 Revenue
5M ago
Neuren Pharmaceuticals Posts Sharp Profit Decline
PremiumCompany Announcements
Neuren Pharmaceuticals Posts Sharp Profit Decline
5M ago
Neuren Aims to Transform Neurodevelopmental Care
PremiumCompany AnnouncementsNeuren Aims to Transform Neurodevelopmental Care
5M ago
Neuren Pharmaceuticals Director Increases Stake
Premium
Company Announcements
Neuren Pharmaceuticals Director Increases Stake
5M ago
Neuren Pharmaceuticals Reports Phase 2 Trial Milestone
Premium
Company Announcements
Neuren Pharmaceuticals Reports Phase 2 Trial Milestone
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >